Share on facebook Facebook Share on twitter Twitter Share on pinterest Pinterest Share on whatsapp WhatsApp Share on email Email We probably should start to use the term “Somatostatin Receptor PET” (SSTR PET) a bit more. We got used to using the term Ga68 PET but since then we have an approved copper version known […]
Share on facebook Facebook Share on twitter Twitter Share on pinterest Pinterest Share on whatsapp WhatsApp Share on email Email I talk often about my diagnosis but not about an ‘incident’ which occurred almost immediately prior to being formally told. I was well into the ‘diagnostic phase’, having had all sorts of tests including a […]
Share on facebook Facebook Share on twitter Twitter Share on pinterest Pinterest Share on whatsapp WhatsApp Share on email Email Scope This summary provides an overview of the types of therapy known for treating Neuroendocrine Cancer. They will have been approved at least by one national or regional approval agency, may not be available or […]
Share on facebook Facebook Share on twitter Twitter Share on pinterest Pinterest Share on whatsapp WhatsApp Share on email Email Overview Many thanks for the support in February both on public pages and in my group – in fact the group’s statistics are totally booming – that is helping a lot of people. My public […]
Share on facebook Facebook Share on twitter Twitter Share on pinterest Pinterest Share on whatsapp WhatsApp Share on email Email On Rare Disease Day, what’s wrong with a bit of Neuroendocrine Cancer awareness? Well, there are three main things wrong with Neuroendocrine Cancer awareness: 1. The incidence and prevalence of Neuroendocrine Neoplasms (the combination of […]
[…] Ronny’s latest post – BREAKING NEWS – US FDA Approves Lutetium Lu 177 dotatate (Lutathera®) – PRRT? […]
Positive Reinforcement – Required Treatment
https://polldaddy.com/js/rating/rating.js
😊
Excellent research Ronny. Getting a global view of the current status will be very helpful to any folks unable to receive the PRRT in their homeland.
Big Thankyou for your continued efforts and sharing data as you receive it!!!
https://polldaddy.com/js/rating/rating.js